PHI with Emphysematous asthma
How does this condition affect your private health insurance?
Emphysemasthma, a term combining features of emphysema and asthma, denotes a severe, chronic respiratory condition characterized by persistent airway obstruction. It involves irreversible damage to the lung's air sacs, leading to reduced elastic recoil typical of emphysema, alongside reversible airway inflammation and hyperresponsiveness seen in asthma. Patients experience chronic shortness of breath, wheezing, cough, and frequent exacerbations. This hybrid pathology results in progressive lung function decline and significantly impacts quality of life. Management aims to control symptoms, minimize inflammation, and prevent further lung damage, but complete recovery is rare due to the irreversible emphysematous component.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Days to several weeks for an acute exacerbation, often requiring hospitalization.
Duration of Illness (Lifetime)
Chronic, progressive disease lasting a lifetime, with periods of stability and acute exacerbations.
Cost of Treatment (Initial)
Several thousands to tens of thousands of USD for an acute exacerbation (hospitalization, medications, diagnostics).
Cost of Treatment (Lifetime)
Hundreds of thousands to millions of USD over a lifetime, including chronic medications, oxygen therapy, and frequent medical visits.
Mortality Rate
Moderate to high (10-50% within 5-10 years for severe cases), primarily due to respiratory failure or complications.
Risk of Secondary Damages
Very high (>70-80%), including cor pulmonale, respiratory failure, pneumonia, anxiety, depression, and significant disability.
Probability of Full Recovery
Very low (<5-10%), as the emphysematous component causes irreversible structural lung damage. Asthma symptoms may be controlled, but the underlying damage remains.
Underlying Disease Risk
High (60-80%). Common comorbidities include cardiovascular diseases, diabetes, osteoporosis, anxiety, depression, and gastroesophageal reflux disease (GERD).